In C1 subtype, cell cycle-related pathways such as E2F targets, G2M checkpoint, MYC targets, and DNA repair were strikingly enriched, while immune response-related pathways were relatively inhibited, which was consistent with high tumor proliferation rate of C1. The gene discussed is MYC; the disease is neoplasm.